Multi-omics study utilizing electronic genome mapping (EGM) reveals 70% of patients with interstitial cystitis/bladder pain syndrome (IC/BPS) have psychiatric comorbidities...
San Diego, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Endure Biotherapeutics, Inc. (Endure Bio®), a pioneer in engineered engraftable microbial therapeutics,...
New contribution will help expand access to care by strengthening the Patient Advocate Foundation's capacity to deliver essential services and...
On track to initiate TRX319 Phase 1/2a dose-escalation trial in early 2026 TRX319 is an allogeneic CAR-Tr1 Treg cell therapy...
Remedy Robotics has been selected by the Australian Stroke Alliance as its exclusive robotics partner to expand access to endovascular thrombectomy,...
The free, online event at 7 p.m. ET on Tuesday, November 11, 2025, will feature presentations from patient advocate Jessie...
– An analysis designed to evaluate the potential effects of the Phase 3 zorevunersen dosing regimen showed continuing improvements in...
New Oracle Health Connection Hub delivers single, unified console to enable data sharing control, auditing, and governance so health systems...
– Data demonstrate ATH434 slows disease progression and stabilizes orthostatic hypotension – – New analysis increases overall confidence in the...
The Fund for Congolese Women named 2025 .ORG of the Year, selected from nearly 3,000applicants from more than 120 countries...
With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping...
Groundbreaking remotely operable robotic system to transform intervention for stroke and cardiovascular disease, while radically expanding access to care for...
ATLANTA, Oct. 6, 2025 /PRNewswire/ -- In recognition of Sudden Cardiac Arrest Awareness Month, CENTEGIX is partnering with the Sudden...
Revolutionary technology empowers parents with advanced insights about their children's development, transforming reactive pediatric care into proactive health monitoring WINNIPEG,...
Clario partners with the University of Oxford's NeuroMetrology Lab to transform Parkinson's disease research with the Opal® wearable sensor system. Partnership...
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced...
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic...
BELLEVUE, Wash.--(BUSINESS WIRE)--Symetra Life Insurance Company announced that its acquisition through reinsurance of Dearborn Group’s life and disability (LAD) business...
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company...
First and Only REN-Based Migraine Treatment Approved in China BEIJING and NETANYA, Israel, Sept. 29, 2025 /PRNewswire/ -- Pier 88 Health, a...